ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Impact Of Antifungal Prophylaxis Discontinuation On Immunosuppression In Lung Transplant Recipients

R. Huntsman, K. Neuhaus

Pharmacy, Cleveland Clinic, Cleveland, OH

Meeting: 2022 American Transplant Congress

Abstract number: 9052

Keywords: Drug interaction, Immunosuppression, Lung transplantation

Topic: Clinical Science » Pharmacy » 29 - Non-Organ Specific: Pharmacokinetics / Pharmacogenomics / Drug interactions

Session Information

Session Name: Pharmacy I

Session Type: Poster Abstract

Date: Sunday, June 5, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: The purpose of this study is to characterize the impact of antifungal discontinuation on immunosuppressant levels and incidence of acute rejection and fungal infections in lung transplant recipients.

*Methods: This single-center, retrospective cohort study with a nested case control will include adult recipients of a lung transplant (single-, double, heart-lung, or lung-liver) during the timeframe of February 3, 2020 to May 1, 2021. Use of posaconazole or voriconazole for fungal prophylaxis and a calcineurin inhibitor (tacrolimus or cyclosporine) for maintenance immunosuppression is also required. Data to be collected will include demographic information, transplant information, pharmacotherapy of immunosuppression and antifungal prophylaxis, dates and results of graft biopsies, and dates and results of fungal cultures. Data will be analyzed using descriptive statistics and univariate analysis.

*Results: One hundred and thirty six patients received a lung transplant during the study timeframe. Ninety eight (72.05%) met inclusion criteria and were included for analysis. Data were analyzed for two groups of patients – those who had the azole discontinued in the outpatient setting (N= 70, 71.43%) and those with discontinuation during a hospital admission (N= 28, 28.57%). A majority of patients (N=58, 82.86%) with outpatient azole discontinuation had preemptive calcineurin inhibitor dose adjustments. The average change in calcineurin inhibitor trough after discontinuation was a decrease of 1.20 ng/mL (SD 7.88) and an increase of 78 ng/mL (SD 81.83) for tacrolimus and cyclosporine, respectively. It took an average of 21.6 days (SD 22.09) and 2.29 dose adjustments (SD 1.90) after azole discontinuation for the calcineurin trough to reach predefined therapeutic levels (10 ng/mL tacrolimus and 200 ng/mL cyclosporine). Subtherapeutic calcineurin inhibitor troughs did not significantly impact the incidence of acute rejection or fungal infection.

*Conclusions: Azole antifungal discontinuation in the outpatient setting impacted the amount of time patients spent with subtherapeutic calcineurin inhibitor trough concentrations, despite seemingly small average changes in trough concentrations.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Huntsman R, Neuhaus K. Impact Of Antifungal Prophylaxis Discontinuation On Immunosuppression In Lung Transplant Recipients [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-antifungal-prophylaxis-discontinuation-on-immunosuppression-in-lung-transplant-recipients/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences